ABCG2 and epilepsy: For another, one mechanism causing difficulties in remedying CNS diseases using pharmacotherapy (e.g., epilepsy and HIV-related neurological conditions) is the obstacle provided by the activity of ABC transporters in brain barrier tissues (Eng et al., 2022).